Bio-Works Technologies AB

Equities

BIOWKS

SE0007387089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 28/06/2024 BST			5-day change	1st Jan Change
2.45 ^SEK	+3.81%		+2.94%	-65.49%

06-20	Bio-Works Technologies Receives an Additional Order Worth SEK 2.6 Million for WorkBeads	CI
05-24	Bio-Works Technologies AB Approves Appointment of Jonas Ahlen and Thomas Gür as New Board Members	CI

Bio-Works Technologies Receives an Additional Order Worth SEK 2.6 Million for WorkBeads

June 20, 2024 at 03:47 pm

Bio-Works Technologies has received another order from a production customer in India who placed an order earlier this year. The latest order for Work Beads is worth SEK 2.6 million. The customer is a manufacturer of bio-therapeutics.

Latest news about Bio-Works Technologies AB

Bio-Works Technologies Receives an Additional Order Worth SEK 2.6 Million for WorkBeads	06-20	CI
Bio-Works Technologies AB Approves Appointment of Jonas Ahlen and Thomas Gür as New Board Members	05-24	CI
Sweden's Bio-Works Technologies Recruits New CEO	05-17	MT
Bio-Works Technologies AB Announces Executive Changes	05-17	CI
Bio-Works Receives an Additional Order Worth SEK 2.9 Million for Workbeads	05-07	CI
Bio-Works Technologies AB Announces Johan Sedihn Declines Re-Election as Member of Board	04-25	CI
Bio-Works Technologies AB Confirms New Order from Indian Biotherapeutic Manufacturer Worth SEK 3.1 Million	04-16	CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-19	CI
Bio-Works Expands Product Range with Introduction of WorkBeads 40 Butyl SH	02-16	CI
Bio-Works Technologies Books SEK1.9 Million Workbeads Resin Order	01-18	MT
Bio-Works Receives Repeat Order for Workbeads Resin	01-18	CI
Bio-Works Technologies AB's Nomination Committee for the 2024 Annual General Meeting	11-09	CI
Bio-Works Technologies Books Order from American Gene Therapy Products Manufacturer	25/10/23	MT
Bio-Works Secures SEK 0.8 Million Order for Gene Therapy Manufacturing	25/10/23	CI
Bio-Works Technologies AB Reports Sales Results for the Third Quarter of 2023	09/10/23	CI
Sweden's Bio-Works Technologies Names CFO	06/09/23	MT
Bio-Works Technologies AB Announces Appointment of Arne Hauge as Chief Financial Officer	06/09/23	CI
Bio-Works Technologies AB Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Bio-Works Technologies to Reduce Workforce Under Restructuring Program; Shares Down 10%	29/05/23	MT
Bio-Works Implements Restructuring Program	29/05/23	CI
Patrick Van De Velde Declines Re-Election as Director At Bio-Works Technologies	22/02/23	CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2022	17/02/23	CI
Sweden's Bio-Works Technologies Books SEK3.4 Million GoBio Order	20/01/23	MT
Bio-Works Confirms New Order for Gobio Prepacked Columns to the American Market	20/01/23	CI
Bio-Works Technologies Enters Finnish Distribution Deal With Biotop	11/01/23	MT

Chart Bio-Works Technologies AB

Duration

Period

More charts

Company Profile

Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

15/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BIO-WORKS TECHNOLOGIES AB	-65.49%	9.01M
ABBOTT LABORATORIES	-5.60%	181B
MEDTRONIC PLC	-4.45%	101B
BECTON, DICKINSON AND COMPANY	-4.15%	67.54B
DEXCOM, INC.	-8.63%	45.09B
CENCORA, INC.	+9.70%	44.37B
HOYA CORPORATION	+6.13%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	29.85B
TERUMO CORPORATION	+14.80%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.99B

Other Medical Equipment, Supplies & Distribution